Summit Financial Strategies, Inc. Geron Corp Transaction History
Summit Financial Strategies, Inc.
- $1.08 Billion
- Q3 2025
A detailed history of Summit Financial Strategies, Inc. transactions in Geron Corp stock. As of the latest transaction made, Summit Financial Strategies, Inc. holds 27,000 shares of GERN stock, worth $33,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,000
Previous 27,000
-0.0%
Holding current value
$33,750
Previous $38,000
5.26%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GERN
# of Institutions
283Shares Held
504MCall Options Held
884KPut Options Held
571K-
Ra Capital Management, L.P. Boston, MA60.4MShares$75.5 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$58.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$53.8 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.4MShares$43 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$34 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $472M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...